Berenberg analyst Gaurav Goparaju downgraded PhenomeX (CELL) to Hold from Buy with a price target of $1, down from $8, citing Bruker’s (BRKR) plans to acquire the company. The firm cites the pending deal for the downgrade.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CELL: